Our meta-analysis found that the CRC patients with high FoxP3+ Tregs infiltration showed superior CSS than those with low FoxP3+ Tregs infiltration (HR = 0.70, 95% CI = 0.62–0.80, P < 0.001, fixed model) (Figure 2). This evidence concerns the gene FOXP3 and colorectal carcinoma.